...
首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >Association of Reactions After Consecutive Acellular or Whole-Cell Pertussis Vaccine Immunizations
【24h】

Association of Reactions After Consecutive Acellular or Whole-Cell Pertussis Vaccine Immunizations

机译:连续脱细胞或全细胞百日咳疫苗免疫后反应的关联

获取原文
           

摘要

Objective . To evaluate the relative frequency of adverse reactions after initial and subsequent immunizations among infants receiving primary immunization with acellular (DTaP) or whole-cell (DTP) pertussis vaccine with diphtheria and tetanus combined.Methods . We examined the occurrence of common reactions in 2127 infants within 48 hours after immunization at 2, 4, and 6 months with one of 13 DTaP or with Lederle DTP (WCL). Data on at least two consecutive immunizations were available for 357 WCL recipients and 1770 DTaP recipients. For these analyses, reactions evaluated included fever of 100.4°F (38°C) or greater, redness of 21 mm or larger, swelling of 21 mm or larger, moderate or severe pain, moderate or severe fussiness, loss of appetite, drowsiness, and vomiting.Results . With one exception, reactions were approximately 1.5 to 8 times more likely to occur in WCL recipients if the same reaction had been observed at the previous immunization (the single exception was redness after the second immunization). Both initial and repeated reactions were less likely in DTaP than in WCL recipients. As with WCL recipients, risks of repeated reactions in DTaP recipients were higher than the risks of initial reactions (from 2.5 to 24 times as high).Conclusion . Reactions after a second or third immunization with either WCL or DTaP vaccine are more likely to occur in infants who had the same reaction after the preceding immunization. Absolute risks of repeated reactions tended to be lower after DTaP vaccine than after the WCL vaccine.
机译:目标。评估初次免疫和接种白喉和破伤风联合脱细胞百日咳或脱细胞百日咳疫苗的初次免疫接种婴儿的不良反应相对频率。我们检查了在13,DTaP之一或Lederle DTP(WCL)接种后2、4和6个月内48小时内2127例婴儿的常见反应。 357名WCL接受者和1770名DTaP接受者可获得至少两次连续免疫的数据。对于这些分析,所评估的反应包括发烧100.4°F(38°C)或更高,发红21毫米或更大,肿胀21毫米或更大,中度或重度疼痛,中度或重度烦躁,食欲不振,嗜睡,和呕吐。结果。除了一个例外,如果在前一次免疫中观察到相同的反应,则在WCL受体中发生反应的可能性大约是1.5到8倍(唯一的例外是第二次免疫后发红)。与WCL接受者相比,DTaP中初始和重复反应的可能性均较小。与WCL接受者一样,DTaP接受者中重复反应的风险高于初始反应的风险(高2.5到24倍)。使用WCL或DTaP疫苗进行第二次或第三次免疫后的反应更可能发生在先前免疫后具有相同反应的婴儿中。 DTaP疫苗接种后,重复反应的绝对风险往往低于WCL疫苗接种后。
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号